Loading clinical trials...
Loading clinical trials...
Effectiveness of Thiopurine Dose Optimization by NUDT 15 R139C on Reducing Thiopurine-induced Leucopenia in Inflammatory Bowel Disease
Conditions
Interventions
Pre-genotype NUDT15 and optimize azathioprine dosage
Locations
1
China
The Sixth Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
Start Date
July 1, 2016
Primary Completion Date
May 1, 2018
Completion Date
August 1, 2018
Last Updated
May 17, 2018
Lead Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions